NO20071823L - Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker - Google Patents

Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker

Info

Publication number
NO20071823L
NO20071823L NO20071823A NO20071823A NO20071823L NO 20071823 L NO20071823 L NO 20071823L NO 20071823 A NO20071823 A NO 20071823A NO 20071823 A NO20071823 A NO 20071823A NO 20071823 L NO20071823 L NO 20071823L
Authority
NO
Norway
Prior art keywords
polypropylene glycol
permeation enhancer
testosterone gels
testosterone
gels
Prior art date
Application number
NO20071823A
Other languages
English (en)
Other versions
NO341780B1 (no
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of NO20071823L publication Critical patent/NO20071823L/no
Publication of NO341780B1 publication Critical patent/NO341780B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen angår testosteroninneholdende farmasøytiske sammensetninger og geler samt metoder som anvender disse.
NO20071823A 2004-09-09 2007-04-10 Testosterongeler omfattende polypropylenglykol og isopropylmyristat som gjennomtrengningsforsterker NO341780B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
US63836004P 2004-12-23 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (2)

Publication Number Publication Date
NO20071823L true NO20071823L (no) 2007-06-11
NO341780B1 NO341780B1 (no) 2018-01-22

Family

ID=34931375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071823A NO341780B1 (no) 2004-09-09 2007-04-10 Testosterongeler omfattende polypropylenglykol og isopropylmyristat som gjennomtrengningsforsterker

Country Status (12)

Country Link
US (1) US20080038220A1 (no)
EP (3) EP1634583A1 (no)
KR (1) KR20070099532A (no)
CN (1) CN101018542B (no)
AU (1) AU2005281809A1 (no)
CA (1) CA2578225C (no)
DK (1) DK1786398T3 (no)
ES (1) ES2548723T3 (no)
NO (1) NO341780B1 (no)
UA (1) UA87158C2 (no)
WO (1) WO2006027278A1 (no)
ZA (1) ZA200701864B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO344564B1 (no) * 2005-10-12 2020-02-03 Unimed Pharmaceuticals Llc Forbedret testosterongel og fremgangsmåte til anvendelse

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
US20070154533A1 (en) * 2005-04-13 2007-07-05 Dudley Robert E Method of increasing testosterone and related steriod concentrations in women
US8067399B2 (en) * 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
BRPI0611134A2 (pt) 2005-06-03 2010-08-17 Acrux Dds Pty Ltd método e composição para liberação transdérmica de fármaco
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
ZA200904568B (en) 2007-01-11 2010-09-29 Acrux Dds Pty Ltd Spreading implement
US20090285893A1 (en) * 2008-05-19 2009-11-19 The Procter & Gamble Company Treatment of heart failure in women
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
EP2340043A4 (en) * 2008-10-31 2012-09-19 Moberg Derma Ab TOPICAL COMPOSITION COMPRISING A COMBINATION OF AT LEAST TWO PENETRATION AGENTS
WO2010066810A1 (en) * 2008-12-11 2010-06-17 Besins Healthcare Transdermal pharmaceutical compositions comprising a serm
WO2011046522A2 (fr) * 2009-10-16 2011-04-21 Rached Smida Nouvelles applications de la testosterone libre reconstituee
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
US20160361321A1 (en) * 2014-02-25 2016-12-15 Intas Pharmaceuticals Limited Stable transdermal testosterone gel

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
PT1510213E (pt) * 1997-11-10 2009-02-12 Strakan Internat Ltd Uma Socie Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
US6582724B2 (en) * 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
JP2004524267A (ja) * 2000-08-30 2004-08-12 ユニメッド・ファーマシューティカルズ・インコーポレーテッド 男性の***障害の治療方法、及び性衝動の増強方法
EE05318B1 (et) * 2000-12-22 2010-08-16 Dr. August Wolff Gmbh & Co. Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hpogonadismi raviks
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
ES2330188T3 (es) * 2001-12-07 2009-12-07 Besins Manufacturing Belgium Composicion farmaceutica en forma de gel o de solucion a base de dihidrotestoterona, su procedimiento de preparacion y sus utilizaciones.
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
RS52671B (en) * 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc IMPROVED TESTOSTERON GEL AND USE PROCEDURE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO344564B1 (no) * 2005-10-12 2020-02-03 Unimed Pharmaceuticals Llc Forbedret testosterongel og fremgangsmåte til anvendelse
NO346660B1 (no) * 2005-10-12 2022-11-21 Unimed Pharmaceuticals Llc Forbedret testosterongel og fremgangsmåte til anvendelse

Also Published As

Publication number Publication date
US20080038220A1 (en) 2008-02-14
EP1786398A1 (en) 2007-05-23
WO2006027278A1 (en) 2006-03-16
EP2957279A1 (en) 2015-12-23
DK1786398T3 (en) 2015-11-23
CA2578225C (en) 2014-06-03
NO341780B1 (no) 2018-01-22
KR20070099532A (ko) 2007-10-09
ES2548723T3 (es) 2015-10-20
CA2578225A1 (en) 2006-03-16
AU2005281809A1 (en) 2006-03-16
EP1634583A1 (en) 2006-03-15
CN101018542A (zh) 2007-08-15
EP1786398B1 (en) 2015-08-12
ZA200701864B (en) 2008-05-28
CN101018542B (zh) 2020-05-19
EP2957279B1 (en) 2022-11-02
UA87158C2 (ru) 2009-06-25

Similar Documents

Publication Publication Date Title
NO20071823L (no) Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DK1869019T3 (da) Bicycliske [3.1.0]heteroarylamider som glycintransportinhibitorer type I
DE602005011976D1 (de) Milde, feuchtigkeitsspendende reinigungszusammensetzungen
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE471931T1 (de) Verbindungen, zusammensetzungen und verfahren
NO20063393L (no) Farmasoytiske preparater
HN2005035436A (es) Caja de empaque
TW200609664A (en) Aqueous edge bead remover
HN2005035438A (es) Caja de empaque
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.
TW200631589A (en) Varnish composition based on a solvent of plant origin
MX2007002814A (es) Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion.
DE602005011314D1 (de) 4-hydroxytamoxifengel-formulierungen
ATE556128T1 (de) Benzinzusammensetzungen
HN2005035440A (es) Caja de empaque
ES1057641Y (es) Botellero plegable.
FI20041286A (fi) Postituspullo
UA8453S (uk) Пляшка для горілки
UA8292S (uk) Пляшка для горілки
UA8069S (uk) Пляшка для горілки
UA8258S (uk) Пляшка для горілки
UA6630S (uk) Пляшка для горілки

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL, LU

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BESINS HEALTHCARE LUXEMBOURG SARL, LU